Arcus Biosciences Inc (RCUS)
15.50
0.00 (0.00%)
USD |
NYSE |
May 02, 16:00
15.49
-0.01
(-0.06%)
Pre-Market: 20:00
Arcus Biosciences 1 Year Total Returns (Daily): -13.12% for May 2, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 02, 2024 | -13.12% |
| May 01, 2024 | -15.94% |
| April 30, 2024 | -14.68% |
| April 29, 2024 | -12.44% |
| April 26, 2024 | -13.56% |
| April 25, 2024 | -20.12% |
| April 24, 2024 | -20.09% |
| April 23, 2024 | -22.46% |
| April 22, 2024 | -26.56% |
| April 19, 2024 | -23.93% |
| April 18, 2024 | -20.56% |
| April 17, 2024 | -21.73% |
| April 16, 2024 | -9.52% |
| April 15, 2024 | -7.13% |
| April 12, 2024 | -2.30% |
| April 11, 2024 | -2.32% |
| April 10, 2024 | -3.63% |
| April 09, 2024 | -0.68% |
| April 08, 2024 | -3.41% |
| April 05, 2024 | -2.75% |
| April 04, 2024 | -3.47% |
| April 03, 2024 | -3.02% |
| April 02, 2024 | -2.85% |
| April 01, 2024 | 1.32% |
| March 28, 2024 | 7.15% |
| Date | Value |
|---|---|
| March 27, 2024 | 3.17% |
| March 26, 2024 | -5.51% |
| March 25, 2024 | -6.53% |
| March 22, 2024 | 2.94% |
| March 21, 2024 | 3.05% |
| March 20, 2024 | 5.74% |
| March 19, 2024 | 5.17% |
| March 18, 2024 | 4.68% |
| March 15, 2024 | 11.91% |
| March 14, 2024 | 6.70% |
| March 13, 2024 | 10.95% |
| March 12, 2024 | 12.63% |
| March 11, 2024 | 14.86% |
| March 08, 2024 | 1.18% |
| March 07, 2024 | 1.41% |
| March 06, 2024 | 8.83% |
| March 05, 2024 | 2.90% |
| March 04, 2024 | 4.16% |
| March 01, 2024 | 9.64% |
| February 29, 2024 | 5.05% |
| February 28, 2024 | 5.16% |
| February 27, 2024 | 11.25% |
| February 26, 2024 | 7.37% |
| February 23, 2024 | 4.66% |
| February 22, 2024 | 3.04% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-57.18%
Minimum
Nov 30 2023
341.3%
Maximum
Feb 02 2021
29.74%
Average
-8.67%
Median
Aug 04 2022
1 Year Total Returns (Daily) Benchmarks
| Gilead Sciences Inc | -15.58% |
| Catalyst Pharmaceuticals Inc | -9.63% |
| Integra Lifesciences Holdings Corp | -45.00% |
| Palatin Technologies Inc | -6.82% |
| Petros Pharmaceuticals Inc | -83.16% |